MAX VISION tablet: A perfect formulation to support the treatment of age related macular degeneration & Dry eye syndrome

Abstract

ARMD (Age Related Macular Degeneration), Cataract & dry eye syndrome is multifactorial diseases associated with
several risk factors and it is responsible for 50% of blindness worldwide. At present, the only remedy for cataract is
surgery. However the incidence is so large that the available surgical facilities are unable to cope up with the problem
because of postoperative complications such as posterior capsular Opacification, Endophthalmitis and uncorrected
residual refractive error. In India alone around 30 million people suffer from cataract. Thus, the expense and
unavailability of surgery mean that non-surgical medical therapy or nutritional treatment to inhibit the formation or
slow the progression of cataracts is an important goal in experimental eye research to benefit patients and reduce the
huge economic burden. The present Article reviews the role of MAX VISION tablet for eyes to prevent ARMD (Age
Related Macular Degeneration), Cataract & dry eye syndrome.